A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant for Clostridium difficile Infection in Immunocompromised Patients

BACKGROUND: Fecal microbiota transplantation (FMT) has been shown to be effective in recurrent Clostridium difficile (CD) infection, with resolution in 80% to 90% of patients. However, immunosuppressed patients were often excluded from FMT trials, so safety and efficacy in this population are unknow...

Descripción completa

Detalles Bibliográficos
Autores principales: Shogbesan, Oluwaseun, Poudel, Dilli Ram, Victor, Samjeris, Jehangir, Asad, Fadahunsi, Opeyemi, Shogbesan, Gbenga, Donato, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139215/
https://www.ncbi.nlm.nih.gov/pubmed/30246002
http://dx.doi.org/10.1155/2018/1394379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139215/
https://www.ncbi.nlm.nih.gov/pubmed/30246002
http://dx.doi.org/10.1155/2018/1394379

Ejemplares similares